Systemic modulation with mult-factors involved in the viro-immunotherapy of cancer
- At: 2007 FIP Congress in Beijing (China)
- Type: Presentation
- By: HU, Fang (Shanghai Sunway Biotech Co.Ltd, Shanghai, China)
The clinical proof of concept on the local effect of oncolytic virotherapy has been achieved in several clinical trials. However, clinical experiences show that the local therapies alone are not efficient enough to induce systemic tumor regression, which is crucial to the clinical eradication of metastatic tumors. Utilizing released mutated tumor.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.